US$ 28.30
ipamorelin human study growth hormone secretagogue clinical trial secretagogues: history, mechanism of action, and development - Ishida - 2020 - JCSM Rapid Communications Thaiger Ipamorelin Selective Growth Hormone
Description
20242025 flu season

10.3724/SP.J.1009.2016.00031 186 MohammadiS.FakhriS.Mohammadi-FaraniA.FarzaeiM

Venetoclax Combined with Cladribine + Low Dose AraC (LDAC) Alternating with 5-azacytidine Produces High Rates of Minimal Residual Disease (MRD) Negative Complete Remissions (CR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

doi: 10.15212/AMM-2023-0039